| Issue |
Title |
File |
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol , No (0) |
|
|
|
|
| Vol 16, No 10 (2016) |
1,3,4-Thiadiazole Based Anticancer Agents |
(Eng)
|
|
Aliabadi A.
|
| Vol 24, No 10 (2024) |
1,3-Diaryl Triazenes Incorporating Disulfonamides Show Both Antiproliferative Activity and Effective Inhibition of Tumor-associated Carbonic Anhydrases IX and XII |
(Eng)
|
|
Lolak N., Akocak S., Petreni A., Budak Y., Bozgeyik E., Gurdere M., Ceylan M., Supuran C.
|
| Vol 14, No 4 (2014) |
1-O-Octadecyl-2-O-Methylglycero-3-phosphocholine (Edelfosine) and Cancer Cell Invasion: A Short Review |
(Eng)
|
|
Slambrouck S., Steelant W.
|
| Vol 23, No 12 (2023) |
3-Bromopyruvate Inhibits the Growth and Glucose Metabolism of TNBC Xenografts in Nude Mice by Targeting c-Myc |
(Eng)
|
|
Pan J., Li J., Yang C., Xiao W., Li Q., Luo X., Zhang X.
|
| Vol 14, No 5 (2014) |
3-Bromopyruvic Acid, A Hexokinase II Inhibitor, is an Effective Antitumor Agent on the Hepatoma Cells : in vitro and in vivo Findings |
(Eng)
|
|
Gong L., Wei Y., Yu X., Peng J., Leng X.
|
| Vol 15, No 6 (2015) |
4,6-diaryl Pyrimidones as Constrained Chalcone Analogues: Design, Synthesis and Evaluation as Antiproliferative Agents |
(Eng)
|
|
Kumar D., Nepali K., Bedi P., Kumar S., Malik F., Jain S.
|
| Vol 16, No 12 (2016) |
4-Anilinoquinazoline Derivatives with Epidermal Growth Factor Receptor Inhibitor Activity |
(Eng)
|
|
Liu F., Tang B., Liu H., Li L., Liu G., Cheng Y., Xu Y., Chen W., Huang Y.
|
| Vol 15, No 6 (2015) |
5-Benzylidene-3,4-dihalo-furan-2-one derivatives inhibit human leukemia cancer cells through suppression of NF-κB and GSK-3β |
(Eng)
|
|
Wang F., Lin J., Hou W., Huang M., Sun P., Chen W.
|
| Vol 15, No 8 (2015) |
5-Lipoxygenase and Cyclooxygenase Inhibitory Dammarane Triterpenoid 1 from Borassus flabellifer Seed Coat Inhibits Tumor Necrosis Factor-α Secretion in LPSInduced THP-1 Human Monocytes and Induces Apoptosis in MIA PaCa-2 Pancreatic Cancer Cells |
(Eng)
|
|
Sastry Yarla N., Azad R., Basha M., Rajack A., Kaladhar D.S., Kumar Allam B., Rao. Pragada R., Nand Singh K., Kumari K S., Pallu R., Parimi U., Bishayee A., Rao. Duddukuri G.
|
| Vol 10, No 4 (2010) |
A Better Platinum-Based Anticancer Drug Yet to Come? |
(Eng)
|
|
Olszewski U., Hamilton G.
|
| Vol 13, No 2 (2013) |
A Cohort Study and Meta-Analysis between Histopathological Classification and Prognosis of Gastric Carcinoma |
(Eng)
|
|
Liu L., W. Wang Z., Ji J., N. Zhang J., Yan M., Zhang J., Y. Liu B., G. Zhu Z., Y. Yu Y.
|
| Vol 23, No 19 (2023) |
A Combination of EGFR Inhibitors and AE-PDT Could Synergistically Suppress Breast Cancer Progression |
(Eng)
|
|
Niu Y., Guo X., Han W., Han X., Li K., Tian S., Zhu Y., Bai D., Chen Q.
|
| Vol 11, No 4 (2011) |
A Combination of Two Antioxidants (An SOD Mimic and Ascorbate) Produces a Pro-Oxidative Effect Forcing Escherichia coli to Adapt Via Induction of oxyR Regulon |
(Eng)
|
|
Batinic-Haberle I., Rajic Z., Benov L.
|
| Vol 24, No 3 (2024) |
A Comprehensive Review on Nanoparticles as a Targeted Delivery System for the Treatment of Lung Cancer |
(Eng)
|
|
Gupta T., Varanwal A., Nema P., Soni S., Iyer A., Das R., Soni V., Kashaw S.
|
| Vol 24, No 8 (2024) |
A Contemporary Review on the Critical Role of Nonsteroidal Anti-inflammatory Agents in Colorectal Cancer Therapy |
(Eng)
|
|
Zia Sarabi P., Moradi M., Bagheri M., Khalili M., Moradifard S., Jamialahmadi T., Ghasemi F., Sahebkar A.
|
| Vol 14, No 4 (2014) |
A Fluorescent Alkyllysophospholipid Analog Exhibits Selective Cytotoxicity Against the Hormone-Insensitive Prostate Cancer Cell Line PC3 |
(Eng)
|
|
Samadder P., Byun H., Bittman R., Arthur G.
|
| Vol 24, No 13 (2024) |
A Green Synthesis of Au-Ag Alloy Nanoparticles using Polydopamine Chemistry: Evaluation of their Anticancer Potency Towards Both MCF-7 Cells and their Cancer Stem Cells Subgroup |
(Eng)
|
|
Zhan H., Ding S., Shen R., Lv Y., Tian X., Liu G., Li C., Wang J.
|
| Vol 13, No 2 (2013) |
A Natural Anticancer Agent Thaspine Targets Human Topoisomerase IB |
(Eng)
|
|
Castelli S., Katkar P., Vassallo O., Falconi M., Linder S., Desideri A.
|
| Vol 12, No 6 (2012) |
A New 4-phenyl-1,8-naphthyridine Derivative Affects Carcinoma Cell Proliferation by Impairing Cell Cycle Progression and Inducing Apoptosis |
(Eng)
|
|
Capozzi A., Mantuano E., Matarrese P., Saccomanni G., Manera C., Mattei V., Gambardella L., Malorni W., Sorice M., Misasi R.
|
| Vol 15, No 7 (2015) |
A Novel Approach to Inhibit Heat Shock Response as Anticancer Strategy by Coumarine Compounds Containing Thiazole Skeleton |
(Eng)
|
|
Koca İ., Gumuş M., Ozgur A., Disli A., Tutar Y.
|
| Vol 15, No 6 (2015) |
A Novel Cobalt(II) Coordination Complex Constructed from H2Pyri and 4,4′-Bipy: Synthesis, Characterization and Bioactivity |
(Eng)
|
|
Gao E., Zhao F., Zhu M., Wang M.
|
| Vol 24, No 19 (2024) |
A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated Orphan Drug, for the Treatment of Hepatocellular Carcinoma |
(Eng)
|
|
Keerthana C., Aiswarya S., Rayginia T., Vijayan Y., James S., Shifana S., Sundaram S., Induja D., Lankalapalli R., Harikumar K., Anto R.
|
| Vol 25, No 5 (2025) |
A Novel Effective Models for Identifying BRCA Patients and Optimizing Clinical Treatments |
(Eng)
|
|
Luo Y., Liu L., Hou Z., Xiong D., Chen R.
|
| Vol 12, No 7 (2012) |
A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts |
(Eng)
|
|
Kawakami K., Hattori M., Inoue T., Maruyama Y., Ohkanda J., Kato N., Tongu M., Yamada T., Akimoto M., Takenaga K., Sassa T., Suzumiy J., Honma Y.
|
| Vol 16, No 12 (2016) |
A Novel Method to Synthesize 4-Aryl-1H-1,2,3-Triazoles and its Antihepatoma Activity |
(Eng)
|
|
Li X., He Y., Hai L., Zhang T., Wu Y.
|
| Vol 15, No 1 (2015) |
A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib |
(Eng)
|
|
Roy S., Narang B., Rastogi S., Rawal R.
|
| Vol 15, No 10 (2015) |
A Novel Quinoline Based Second-generation mTOR Inhibitor that Induces Apoptosis and Disrupts PI3K-Akt-mTOR Signaling in Human Leukemia HL-60 Cells |
(Eng)
|
|
Kumar S., Guru S., Venkateswarlu V., Malik F., Vishwakarma R., Sawant S., Bhushan S.
|
| Vol 11, No 7 (2011) |
A Novel Small Molecule Inhibitor of FAK and IGF-1R Protein Interactions Decreases Growth of Human Esophageal Carcinoma |
(Eng)
|
|
A. Ucar D., Cox A., He D., A. Ostrov D., Kurenova E., N. Hochwald S.
|
| Vol 15, No 10 (2015) |
A Novel Triazole Nucleoside Suppresses Prostate Cancer Cell Growth by Inhibiting Heat Shock Factor 1 and Androgen Receptor |
(Eng)
|
|
Xia Y., Wang M., Beraldi E., Cong M., Zoubeidi A., Gleave M., Peng L.
|
| Vol 24, No 17 (2024) |
A Novel Tryptanthrin Derivative D6 Induces Apoptosis and DNA Damage in Non-small-cell Lung Cancer Cells Through Regulating the EGFR Pathway |
(Eng)
|
|
Long H., Zhang G., Zhou Y., Qin L., Zhu D., Chen J., Liu B., Tan H., Chen D., Li Z., Li C., Wang Z.
|
| Vol 24, No 12 (2024) |
A Number of the N-terminal RASSF Family: RASSF7 |
(Eng)
|
|
Xu Y., Du W., Xiao Y., Gao K., Li J., Li S.
|
| Vol 25, No 17 (2025) |
A Path to the Formation Mechanism of Propolis Nanoparticles, their Cytotoxicity on 3T3 Fibroblasts, Metastatic Murine B16F10 Cells, and their In vivo Irritability in Animals |
(Eng)
|
|
Gonzalez-Masis J., Gonzalez-Paz R., Urena Y., Guerrero S., Gonzalez-Camacho S., Mora-Ugalde N., Baizan-Rojas M., Loaiza R., Vega-Baudrit J., Cubero-Sesin J.
|
| Vol 15, No 4 (2015) |
A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation |
(Eng)
|
|
Fatahala S., Shalaby E., Kassab S., Mohamed M.
|
| Vol 25, No 1 (2025) |
A Promising Paradigm Shift in Cancer Treatment with FGFR Inhibitors |
(Eng)
|
|
Mehra A., Sangwan R.
|
| Vol 25, No 6 (2025) |
A Review of Anticancer Potential of Conferone, Diversin and Ferutinin; Which One is Stronger for Cancer Therapy? |
(Eng)
|
|
Keshmirshekan F., Mohamadi-Zarch S., Bagheri S.M.
|
| Vol 15, No 1 (2015) |
A Review on Antiproliferative and Apoptotic Activities of Natural Honey |
(Eng)
|
|
Jaganathan S., Balaji A., Vellayappan M., Asokan M., Subramanian A., John A., Supriyanto E., Razak S., Marvibaigi M.
|
| Vol 15, No 5 (2015) |
A Review on the Synthesis and Anti-cancer Activity of 2-substituted Quinolines |
(Eng)
|
|
Gopaul K., Shintre S., Koorbanally N.
|
| Vol 23, No 20 (2023) |
A Review on the Use of Gold Nanoparticles in Cancer Treatment |
(Eng)
|
|
Sultana R., Yadav D., Puranik N., Chavda V., Kim J., Song M.
|
| Vol 15, No 7 (2015) |
A Role for the Inflammatory Mediators Cox-2 and Metalloproteinases in Cancer Stemness |
(Eng)
|
|
Chimal-Ramírez G., Espinoza-Sanchez N., Fuentes-Panana E.
|
| Vol 13, No 2 (2013) |
A Sample Selection Strategy to Boost the Statistical Power of Signature Detection in Cancer Expression Profile Studies |
(Eng)
|
|
Jia Z., Wang Y., Hu Y., McLaren C., Yu Y., Ye K., Xia X., A. Koziol J., Lernhardt W., McClelland M., Mercola D.
|
| Vol 15, No 5 (2015) |
A Short Review on the Synthetic Strategies of Duocarmycin Analogs that are Powerful DNA Alkylating Agents |
(Eng)
|
|
Patil P., Satam V., Lee M.
|
| Vol 13, No 4 (2013) |
A Small-molecule Inhibitor, 5'-O-Tritylthymidine, Targets FAK and Mdm-2 Interaction, and Blocks Breast and Colon Tumorigenesis in vivo |
(Eng)
|
|
M. Golubovskaya V., L. Palma N., Zheng M., Ho B., Magis A., Ostrov D., G. Cance W.
|
| Vol 14, No 8 (2014) |
A Steroidal Na+/K+ ATPase Inhibitor Triggers Pro-apoptotic Signaling and Induces Apoptosis in Prostate and Lung Tumor Cells |
(Eng)
|
|
Honisch S., Alkahtani S., Kounenidakis M., Liu G., Alarifi S., Al-Yahya H., Dimas K., AlKahtane A., Prousis K., Al-Dahmash B., Calogeropoulou T., Alevizopoulos K., Lang F., Stournaras C.
|
| Vol 25, No 19 (2025) |
A Systematic Quantitative Approach to Rational Drug Design and the Discovery of Novel Human Antigen R (HuR) Inhibitors |
(Eng)
|
|
Dey J., Kaushiki K., Mishra K.A., Sudheer P., Sethi K.K.
|
| Vol 24, No 14 (2024) |
A Systematic Review and Meta-analysis of the Relationship between Statin Intake and Esophageal Cancer |
(Eng)
|
|
Khaghani A., Kasiri K., Heidari-Soureshjani S., Sherwin C., Mardani-Nafchi H.
|
| Vol 23, No 19 (2023) |
A Systematic Review and Meta-analysis on the Role of Statins in the Prevention of Mortality Following Pancreatic Cancer |
(Eng)
|
|
Anbari K., Amiri M., Heidari-Soureshjani S., Sherwin C., Kasiri K.
|
| Vol 10, No 8 (2010) |
ABC Transporters: Unvalidated Therapeutic Targets in Cancer and the CNS |
(Eng)
|
|
W. Robey R., R. Massey P., Amiri-Kordestani L., E. Bates S.
|
| Vol 16, No 2 (2016) |
Acetogenins as Potential Anticancer Agents |
(Eng)
|
|
Mangal M., Khan M., Agarwal S.
|
| Vol 15, No 10 (2015) |
Acknowledgement To Reviewers: |
(Eng)
|
|
|
| Vol 12, No 10 (2012) |
Acknowledgements |
(Eng)
|
|
|
| Vol 24, No 20 (2024) |
Acknowledgements to Reviewers |
(Eng)
|
|
|
| Vol 23, No 20 (2023) |
Acknowledgements to Reviewers |
(Eng)
|
|
|
| Vol 16, No 12 (2016) |
Acknowledgements to Reviewers: |
(Eng)
|
|
|
| Vol 13, No 10 (2013) |
ACKNOWLEDGEMENTS TO THE REVIEWERS |
(Eng)
|
|
.
|
| Vol 14, No 10 (2014) |
Acknowledgements to the Reviewers |
(Eng)
|
|
.
|
| Vol 15, No 8 (2015) |
Acridone-based Antitumor Agents: A Mini-review |
(Eng)
|
|
Alwan W., Mahajan A., Rane R., Amritkar A., Naphade S., Yerigiri M., Karpoormath R.
|
| Vol 14, No 7 (2014) |
Activation of Integrin β1 Mediates the Increased Malignant Potential of Ovarian Cancer Cells Exerted by Inflammatory Cytokines |
(Eng)
|
|
Yang Z., Zhou X., Liu Y., Gong C., Wei X., Zhang T., Ma D., Gao Q.
|
| Vol 25, No 2 (2025) |
Acyl Urea Compounds Therapeutics and its Inhibition for Cancers in Women: A Review |
(Eng)
|
|
Kumari P., Mishra R., Mazumder R., Mazumder A.
|
| Vol 14, No 1 (2014) |
Adenoviral Vectors for Prodrug Activation-based Gene Therapy for Cancer |
(Eng)
|
|
Doloff J., Waxman D.
|
| Vol 14, No 1 (2014) |
Adenoviral Vectors for Prodrug Activation-based Gene Therapy for Cancer |
(Eng)
|
|
Doloff J., Waxman D.
|
| Vol 23, No 13 (2023) |
ADME Prediction, Structure-activity Relationship of Boswellic Acid Scaffold for the Aspect of Anticancer & Anti-inflammatory Potency |
(Eng)
|
|
Kumar A., Sharma S., Mishra S., Ojha S., Upadhyay P.
|
| Vol 25, No 3 (2025) |
Advancements in Pyrazine Derivatives as Anticancer Agents: A Comprehensive Review (2010-2024) |
(Eng)
|
|
Alshahrani M.
|
| Vol 23, No 10 (2023) |
Advancements in Small Molecule PROTACs Containing Indole/Spiro-fused Oxindole Scaffolds: An Emerging Degrader Targeting Cancers |
(Eng)
|
|
Li X., Liu Y., Huang W., Xie X., Zhu H., Peng C., Han B.
|
| Vol 15, No 7 (2015) |
Advances in the Development of Site-Specific Antibody-Drug Conjugation |
(Eng)
|
|
Zhou Q., Kim J.
|
| Vol 14, No 5 (2014) |
Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase |
(Eng)
|
|
Tang J., Wen Q., Sun J., Zhang W., Zhu H.
|
| Vol 13, No 3 (2013) |
Advances in the Systemic Treatment of Neuroendocrine Tumors in the Era of Molecular Therapy |
(Eng)
|
|
Leung R., Lang B., Wong H., Chiu J., K. Yat W., Shek T., Y. Cho W., C. Yau L., Yau T.
|
| Vol 25, No 10 (2025) |
Advances in VEGFR Inhibitors: A Comprehensive Review of Novel Anticancer Agents |
(Eng)
|
|
Jha S., Gupta S., Rani S., Arora P., Choudhary N., Kumar S.
|
| Vol 24, No 18 (2024) |
Agrimonolide Inhibits the Malignant Progression of Non-small Cell Lung Cancer and Induces Ferroptosis through the mTOR Signaling Pathway |
(Eng)
|
|
Zhang X., Cai W., Yan Y.
|
| Vol 23, No 13 (2023) |
ALK and ERBB2 Protein Inhibition is Involved in the Prevention of Lung Cancer Development by Vincamine |
(Eng)
|
|
Verma A., Yadav P., Rajput S., Verma S., Arora S., Kumar R., Bhatti J., Khurana A., Navik U.
|
| Vol 12, No 4 (2012) |
Alteration of Ceramide 1-O-Functionalization as a Promising Approach for Cancer Therapy |
(Eng)
|
|
Ballereau S., Levade T., Genisson Y., Andrieu-Abadie N.
|
| Vol 25, No 2 (2025) |
Alterations of Krüppel-like Factor Signaling and Potential Targeted Therapy for Hepatocellular Carcinoma |
(Eng)
|
|
Fang R., Sha C., Xie Q., Yao D., Yao M.
|
| 1 - 100 of 1242 Items |
1 2 3 4 5 6 7 8 9 10 11 12 13 > >> |
